Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides-Reference-Cited by-同舟云学术

Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides

Published:2015-12 Issue:1 Volume:369 Page:112-123
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Sun Weihong,Wei Xiaofang,Niu Airong,Ma Xuezhen,Li Jian Jian,Gao Daiqing

Funder

NIH

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response;Kawamoto;Oncol. Rep,2011

2. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor;Tomita;Clin. Cancer Res,2013

3. Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study;Amato;Clin. Cancer Res,2010

4. Clinical peptide vaccination trials for leukemia patients;Casalegno-Garduno;Expert Rev. Vaccines,2011

5. Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design;Borbulevych;J. Immunol,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of DNMTs increases neoantigen-reactive T-cell toxicity against microsatellite-stable colorectal cancer in combination with radiotherapy;Biomedicine & Pharmacotherapy;2024-08

2. Disruption of Colorectal Cancer Network by Polyphyllins Reveals Pivotal Entities with Implications for Chemoimmunotherapy;Biomedicines;2022-03-02

3. Analysis of senescence-responsive stress fiber proteome reveals reorganization of stress fibers mediated by elongation factor eEF2 in HFF-1 cells;Molecular Biology of the Cell;2022-01-01

4. Proteome of actin stress fibers;2021-06-01

5. Personal Neoantigens From Patients With NSCLC Induce Efficient Antitumor Responses;Frontiers in Oncology;2021-04-13